Azienda Ospedaliero Universitaria di Sassari-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study

    The Lancet Respiratory Medicine, Vol. 9, Núm. 6, pp. 613-621